Liver Stiffness Measured by Shear-wave Elastography for Evaluating Intrahepatic Portal Hypertension in Children

Hee Mang Yoon1, So Yeon Kim, Kyung Mo Kim

  • 1*Department of Radiology and Research Institute of Radiology †Department of Pediatrics ‡Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

Shear-wave elastography (SWE) accurately predicts clinically significant portal hypertension in children with liver disease. Reliable liver stiffness (LS) measurements using a coefficient of variation (CV) ≤ 0.2 enhance diagnostic accuracy.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Medical Imaging

Background:

  • Portal hypertension is a serious complication of pediatric liver diseases.
  • Accurate, non-invasive methods are needed to assess portal hypertension in children.
  • Shear-wave elastography (SWE) shows promise for evaluating liver stiffness (LS).

Purpose of the Study:

  • To correlate liver stiffness (LS) measured by SWE with hepatic venous-pressure gradient (HVPG).
  • To evaluate SWE's diagnostic performance for predicting clinically significant portal hypertension (CSPH) in children.
  • To assess the reliability of SWE measurements using the coefficient of variation (CV).

Main Methods:

  • 33 SWE measurements were performed on 32 children within 2 weeks of HVPG measurement.
  • Correlation between LS and HVPG was analyzed.
  • Receiver-operating characteristic (ROC) curve analysis assessed diagnostic performance for CSPH (HVPG ≥ 10 mmHg).
  • Reliability was determined by the coefficient of variation (CV).

Main Results:

  • LS significantly correlated with HVPG (r=0.742, P<0.001).
  • SWE demonstrated excellent diagnostic performance for CSPH (AUC=0.914), with a cutoff of 18.4 kPa yielding 87.5% sensitivity and 84.0% specificity.
  • LS measurements with CV ≤ 0.2 showed a strong correlation with HVPG (r=0.774, P<0.001), unlike those with CV > 0.2 (r=0.598, P=0.089).

Conclusions:

  • SWE is a highly effective tool for diagnosing clinically significant portal hypertension in pediatric liver disease.
  • LS measurements with a CV ≤ 0.2 are reliable and recommended for clinical use.
  • SWE offers a valuable, non-invasive alternative to HVPG measurement in children.
Abstract